ICP incidence at nearly 3% worldwide, but varies by region: Study
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Nesfatin-1 (NF-1), a hormone that may ease cellular stress, reduced injury to the placenta in a mouse model of ICP, a study found.| Liver Disease News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
